The Shaw report rates sva as a buy with a valuation ranging from $1.00 to $3.11 per share depending on the evaluation methodology used and the risk weighing applied. Their 12 month target price using compco analysis is $1.20.
It is a good read and can be obtained by contacting [email protected] as per the May investor newsletter released today.
